Table 1.
Associations (χ2- and Fisher exact tests) between nuclear XAF1 protein expression levels and clinico-pathological parameters in clear-cell RCC
| All cases | Total (%) | XAF1 low (%) | XAF1 high (%) | p-value | |
|---|---|---|---|---|---|
| 291 (100) | 152 (52.2) | 139 (47.8) | |||
| Gender | 0.212 | ||||
| Men | 197 (67.7) | 108 (54.8) | 89 (45.2) | ||
| Women | 94 (32.3) | 44 (46.8) | 50 (53.2) | ||
| Age | 0.101 | ||||
| ≤64 | 142 (48.8) | 67 (47.2) | 75 (52.8) | ||
| >64 | 149 (51.2) | 85 (57.0) | 64 (43.0) | ||
| pT-status | 0.040 | ||||
| pT1/2 | 145 (49.8) | 67 (46.2) | 78 (53.8) | ||
| pT3/4 | 146 (50.2) | 85 (58.2) | 61 (41.8) | ||
| Fuhrman grade | <0.001 | ||||
| G 1/2 | 129 (44.3) | 50 (38.8) | 79 (61.2) | ||
| G 3/4 | 162 (55.7) | 102 (63.0) | 60 (37.0) | ||
| Metastases | 0.276 | ||||
| M0/x | 241 (82.8) | 122 (50.6) | 119 (49.4) | ||
| M1 | 50 (17.2) | 30 (60.0) | 20 (40.0) | ||